What Happened? Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells ...

Merck ($MRK) stock rose about 4% on Monday, as of writing, after top Wells Fargo analyst Mohit Bansal upgraded his rating for the pharma company ...

Merck (MRK)’s stock surged by 41%, driven not significantly by revenue but rather by increased profits and heightened ...

Pharmaceutical stock Merck & Co (NYSE:MRK) is up 4% at $101.64 at last glance, after an upgrade from Wells Fargo to "overweight" from "equal weight," with a price-target hike to $125 from $90. The ...

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Stocks to Buy for Medium Term. On November 17, BofA analyst Tim Anderson raised the firm’s price target on Merck & Co., Inc. (NYSE:MRK) to ...

Merck MRK has made substantial investments in strategic mergers and acquisitions (M&A) deals over the past few years to build ...

Merck (MRK) stock in focus as the company urges shareholders to reject a mini-tender offer which stands at a 25% discount to ...

Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting ...

MRK's Winrevair hits its phase II goal in patients with CpcPH tied to HFpEF, setting up phase III plans and a potential path ...

We recently published Wall Street Analysts Like These 10 Stocks. Merck & Co., Inc. (NYSE:MRK) is one of the stocks analysts were recently talking about. Bill Nygren, Oakmark Funds partner and CIO, ...

In addition to Jefferies, Merck & Company also received a Buy from Scotiabank’s Louise Chen in a report issued on November 12. However, on November 14, Morgan Stanley maintained a Hold rating on Merck ...

Merck MRK and AbbVie ABBV are prominent pharmaceutical companies with strong positions in oncology and immunology. AbbVie also operates in aesthetics, neuroscience and eye care, while Merck has a ...